Have a personal or library account? Click to login
Gout – management of a chronic disease: a systematic review Cover

Gout – management of a chronic disease: a systematic review

Romanian Journal of Orthopaedic Surgery and Traumatology
Volume 3 (2020): Issue 1 (June 2020)
By: Petruţa Violeta Filip,  Sorina Laura Diaconu,  Diana Chetroiu,  Denisa Cuciureanu and  Corina Silvia Pop  
Open Access
|Aug 2020

References

  1. 1. Tang SCW. Uric Acid in Chronic Kidney Disease Gout: A Disease of Kings. Contrib Nephrol. Basel, Karger. 2018; 192:77-81.10.1159/00048428129393108
    Search in Google ScholarBack to article
  2. 2. Richette P, Doherty M, Pascual E et al. 2018 updated European League Against Rheumatism based recommendations for the diagnosis of gout. Ann Rheum Dis. 2020; 79(1):31-38.10.1136/annrheumdis-2019-21531531167758
    Search in Google ScholarBack to article
  3. 3. Abhishek A, Roddy AE, Doherty M. Gout – a guide for the general and acute physicians. Clinical Medicine. 2017; 17(1):54-59.10.7861/clinmedicine.17-1-54629758028148582
    Search in Google ScholarBack to article
  4. 4. Coburn BW, Mikuls TR. The Problem with Gout Is That It’s Still Such a Problem. J Rheumatol. 2016; 43(8):8-11.
    Search in Google ScholarBack to article
  5. 5. Hui M, Carr A, Cameron S et al. The British Society for Rheumatology Guideline for the Management of Gout. Rheumatology. 2017; 56(7):e1–e20,6.10.1093/rheumatology/kex15628549177
    Search in Google ScholarBack to article
  6. 6. Michael P, Bs MPR, Monjazeb S, Goodwin BP, Group AR. Ulcerated tophaceous gout. 2019:0-3. Dermatol Online J. 2019; 25(3):1-3.
    Search in Google ScholarBack to article
  7. 7. Hainer BL, Matheson E, Wilkes RT. Diagnosis, Treatment, and Prevention of Gout. Am Fam Physician. 2014; 90(12):831-836.
    Search in Google ScholarBack to article
  8. 8. Singh JA. Racial and Gender Disparities in Patients with Gout. Curr Rheumatol Rep. 2013; 15(2):1-15.10.1007/s11926-012-0307-x354540223315156
    Search in Google ScholarBack to article
  9. 9. Pittman JR, Pharm D, Bross MH. Diagnosis and Management of Gout. Am Fam Physician. 1999; 59(7):1799-1806.
    Search in Google ScholarBack to article
  10. 10. Scirè CA, Manara M, Cimmino MA et al. Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR). Arthritis Res Ther. 2013; 15(5):R101.10.1186/ar4281397909524004577
    Search in Google ScholarBack to article
  11. 11. Yu KH, Luo SF, Liou LB et al. Concomitant Septic and Gouty Arthritis-An Analysis of 30 Cases. 2 Rheumatology (Oxford). 2003; 42(9):1062-6.10.1093/rheumatology/keg29712730521
    Search in Google ScholarBack to article
  12. 12. Moi JHY, Sriranganathan MK, Falzon L et al. Lifestyle Interventions for the Treatment of Gout: A Summary of 2 Cochrane Systematic Reviews. J Rheumatol Suppl. 2014; 92:26-32.10.3899/jrheum.14045925180125
    Search in Google ScholarBack to article
  13. 13. Kuo C, Grainge MJ, Mallen C, Zhang W, Doherty M. Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study. Ann Rheum Dis. 2015; 74:661–667.10.1136/annrheumdis-2013-204463439230724431399
    Search in Google ScholarBack to article
  14. 14. Khanna D, Fitzgerald JD, Khanna PP et al. 2012 American College of Rheumatology Guidelines for Management of Gout Part I: Systematic Nonpharmacologic and Pharmacologic Therapeutic Approaches to Hyperuricemia. NIH Public Access. 2013; 64(10):1431-1446.
    Search in Google ScholarBack to article
  15. 15. Jordan KM, Cameron JS, Snaith M et al. British Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of Gout. Rheumatology (Oxford). 2007; 46(8):1372-4.10.1093/rheumatology/kem056a17522099
    Search in Google ScholarBack to article
  16. 16. HR Jr, Boice JA et al. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis. BMJ. 2002; 324(7352):1488-92.10.1136/bmj.324.7352.1488
    Search in Google ScholarBack to article
  17. 17. Chen LC, Ashcroft DM. Risk of myocardial infarction associated with selective COX-2 inhibitors: Meta-analysis of randomised controlled trials. Pharmacoepidemiol Drug Saf. 2007; 16(7):762-72.18.10.1002/pds.1409
    Search in Google ScholarBack to article
  18. 18. Burns CM, Wortmann RL. Latest evidence on gout management: what the clinician needs to know. Ther Adv Chronic Dis. 2012; 3(6):271-286.10.1177/2040622312462056
    Search in Google ScholarBack to article
  19. 19. Hein J, Janssen M, Hvan de Lisdonk E et al. Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. Lancet. 2008; 371(9627):1854-1860.10.1016/S0140-6736(08)60799-0
    Search in Google ScholarBack to article
  20. 20. Sattui SE, Gaffo AL. Treatment of hyperuricemia in gout: current therapeutic options, latest developments and clinical implications. Ther Adv Musculoskel Dis. 2016; 8(4):145-159.10.1177/1759720X16646703495962627493693
    Search in Google ScholarBack to article
  21. 21. Zhang Y, Neogi T, Chen C et al. Cherry Consumption and the Risk of Recurrent Gout Attacks. Arthritis Rheum. 2012; 64(12):4004-4011.10.1002/art.34677351033023023818
    Search in Google ScholarBack to article
  22. 22. Li Q, Li X, Wang J et al. Diagnosis and treatment for hyperuricemia and gout : a systematic review of clinical practice guidelines and consensus statements. BMJ Open. 2019; 9:e026677.10.1136/bmjopen-2018-026677672046631446403
    Search in Google ScholarBack to article
  23. 23. Vargas-Santos AB, Peloquin CE, Zhang Y, Neogi T. Association of Chronic Kidney Disease With Allopurinol Use in Gout Treatment. JAMA Intern Med. 2018; 178(11):1526-1533.10.1001/jamainternmed.2018.4463624819930304329
    Search in Google ScholarBack to article
  24. 24. Goicoeche M, García de Vinuesa S, Verdalles U et al. Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk. Clin J Am Soc Nephrol. 2010; 5(8):1388-93.10.2215/CJN.01580210292441720538833
    Search in Google ScholarBack to article
  25. 25. Macdonald PA, Eustace D, Palo WA, Streit J et al. Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and Gout. N Engl J Med. 2005; 353:2450-2461.10.1056/NEJMoa05037316339094
    Search in Google ScholarBack to article
  26. 26. Avena-Woods C, Hilas O. Febuxostat (Uloric), A New Treatment Option for Gout. Drug Forecast. 2010; 35(2):82-85.
    Search in Google ScholarBack to article
  27. 27. Guttmann A, Krasnokutsky S, Pillinger MH, Berhanu A. Pegloticase in gout treatment - safety issues, latest evidence and clinical considerations. Ther Adv Drug Saf. 2017; 8(12):379-388.10.1177/2042098617727714570310129204266
    Search in Google ScholarBack to article
DOI: https://doi.org/10.2478/rojost-2020-0011 | Journal eISSN: 2544-8978 | Journal ISSN: 2601-5005
Journal RSS Feed
Language: English
Page range: 70 - 77
Accepted on: Jul 23, 2020
|
Published on: Aug 3, 2020
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
gout,
arthritis,
hyperuricemia
Related subjects:
Medicine,
Basic medical science,
Basic medical science, other,
Clinical medicine,
Surgery,
Surgery, other,
Orthopaedic and trauma surgery

© 2020 Petruţa Violeta Filip, Sorina Laura Diaconu, Diana Chetroiu, Denisa Cuciureanu, Corina Silvia Pop, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 3 (2020): Issue 1 (June 2020)